Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reissue Patent
2008-01-22
2008-01-22
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S557000
Reissue Patent
active
RE040033
ABSTRACT:
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure:
REFERENCES:
patent: 4115574 (1978-09-01), Chakrabarti et al.
patent: 4172831 (1979-10-01), Chakrabarti et al.
patent: 5051516 (1991-09-01), Chakrabarti et al.
patent: 5605897 (1997-02-01), Beasley, Jr. et al.
patent: 5627178 (1997-05-01), Chakrabarti et al.
patent: 5637584 (1997-06-01), Larsen
patent: 5817655 (1998-10-01), Chakrabarti et al.
patent: 5817656 (1998-10-01), Beasley, Jr. et al.
patent: 5817657 (1998-10-01), Beasley, Jr. et al.
patent: 454 436 (1991-10-01), None
Chakrabarti et al., 4-Piperazinyl-10H-thieno[2-3-b][1,5]benzodiazepines as Potential Neuroleptics, Journal of Medicinal Chemistry, vol. 23, No. 8, 1980, pp. 878-884.
C.A. Altar, et al., Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists, Naunyn-Schmiedeberg's Arth. Pharmacol, 1988, 162-168, 338.
H. R. Sullivan, et al.,In vitroThiomethylation—Studies with Flumezapine, Drug Metabolism and Disposition, 1985, 276-278, vol. 13, No. 3.
H. G. Schauzu et al., A Free-Wilson Study of 4-Piperazinyl-10H-thienobenzodiazepine Analogues, Pharmazie, 1983, H 8, 38.
Jiban K. Chakrabarti et al., 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as Potential Neuroleptics, J. Med. Chem., 1980, 878-884, 23.
Jiban K. Chakrabarti et al., 10-Piperzinyl-4H-thieno[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as Potential Neuroleptics, J. Med: Chem., 1980, 884-889, 23.
Jiban K. Chakrabarti et al., Effects of Conformationally Restricted 4-Piperazinyl-10H-thienobenzodiazepine Neuroleptics on Central Dopaminergic and Cholinergic Systems, J. Med. Chem., 1982, 1133-1140, 25.
Jiban K. Chakrabarti et al., Synthesis and Pharmacological Evaluation of CNS Activities of [1,2,3]Triazolo[4,5-b][1,5]-, Imidazolo[4,5-b][1,5]-, and Pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-Triazolo[4,5-b][1,5]benzodiazepines with Neuroleptic Activity, J. Med. Chem, 1989, 2375-2381, 32.
Jiban K. Chakrabarti et al., Synthesis and Pharmacological Evaluation of a Series of 4-Piperazinylpyrazolo[3,4-b]-and -[4,3-b][1,5]benzodiazepines as Potential Anxiolytics, J. Med. Chem., 1989, 2573-2582, 32.
DRL Corrected Conclusion of Law, Mar. 24, 2004.
DRL Corrected Findings of Fact, Mar. 24, 2004.
DRL Corrected Post -Trial Brief, Mar. 24, 2004.
DRL Reply Brief Dec. 10, 2005.
DRL Appeal Brief Aug. 15, 2005.
Lilly v Zenith Goldline-CAFC Dec. 26, 2006.
Lilly's CoL, Apr. 21, 2004.
Lilly's Counter FoF CoL, Apr. 21, 2004.
Lilly's FoF, Apr. 21, 2004.
Lilly's Post-Trial Brief, Apr. 21, 2004.
Lilly's Supplemental Brief, May 7, 2004.
Zenith Post-Trial Brief, Mar. 22, 2004.
Zenith Appeal Brief Aug. 15, 2005.
Zenith Reply Brief, Mar. 22, 2004.
Zenith Reply to Lilly's CoL, May 12, 2004.
Chakrabarti Reba
Hotten Terrence Michael
Tupper David Edward
Coleman Brenda
Eli Lilly and Company
Lentz Nelsen L.
LandOfFree
Process for preparing 2-methyl-thieno-benzodiazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing 2-methyl-thieno-benzodiazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing 2-methyl-thieno-benzodiazepine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2781501